EFSA publishes positive opinion on bovine milk osteopontin
The European Food Safety Authority (EFSA) published an opinion that bovine milk osteopontin(OPN) is safe for use in infant formula, follow-on formula, and ready-to-eat dairy-based meals for children.
Photo © stock.adobe.com/ucchie79
The European Food Safety Authority (EFSA) published an opinion that bovine milk osteopontin(OPN) is safe for use in infant formula, follow-on formula, and ready-to-eat dairy-based meals for children. This opens the door for Arla Foods Ingredients’Lacprodan® OPN-10 to become the first bovine milk osteopontinproduct for infant nutrition approved under the new Novel Food Regulation (EU) 2015/2283.
“We’re delighted by this decision, which is a significant step toward achieving Novel Food approval,” said Anders Steen Jørgensen, director pediatric at Arla Foods Ingredients, in a press release. “It’s a strong signal of trustworthiness in this new ingredient for infant milk formula and opens up new opportunities for formula manufacturers. This is the result of more than five years of hard work from our R&D department, Early Life Nutrition Science teams and regulatory teams. Lacprodan OPN-10 is a fantastic addition to our infant nutrition portfolio and continues our record of being first to market with products in this sector.”
Judge denies CRN’s motion for preliminary injunction but its lawsuit against NY state will proceed
April 23rd 2024The judge in CRN's lawsuit against NY state's law banning the sale of weight management and muscle building supplements to minors has denied its motion for a preliminary injunction, but determined that CRN has standing to sue on behalf of its members.
Arla Foods to acquired whey nutrition business from Volac International
April 22nd 2024Arla Foods Ingredients has reached an agreement to acquire Volac’s Whey Nutrition business through a purchase of shares in Volac Whey Nutrition Holdings Limited and its subsidiary, Volac Whey Nutrition Limited and Volac Renewable Energy Limited.
